EBAG9 and neoplasm: We examined the extent to which EBAG9 downregulation affected the anti-tumor response of BCMA CAR T cells in a NOD.Cg-Prkdcscid Il2rg tm1 Wji/Szj (NSG) mouse xenotransplantation model (Figure 6A).